Patients Stopping Anti-Obesity Injections Put On Pounds at a Quadrupled Rate Compared to Those on Conventional Diets
A recent study suggests that individuals who come off new weight-loss injections like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who halt traditional lifestyle plans.
Findings released in a major health publication shows that while obese individuals often shed a large proportion of their total mass while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month once they quit.
"People buying these drugs must be informed of the risk of fast rebound weight gain when the medication concludes," stated expert Dr. Susan Jebb.
That rate of regain implies a return to original mass within about a year and a half.
Analyzing Therapies
The research, which examined dozens of studies involving thousands of patients, compared the results of the injectable medications with conventional dieting.
Researchers emphasize that individuals who lose weight through dieting usually see a less rapid creep back—perhaps 100 grams monthly—after stopping.
Understanding the Rapid Regain
Experts propose the way of the drugs explains the amplified weight return.
These medications mimic a body's own chemical called GLP-1, which controls appetite.
"Long-term administration of the hormone levels far above than the body's typical production may cause the body to produce less of its own natural GLP-1, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' leads to appetite is unsuppressed, making overeating a significant risk."
A Chronic Condition?
Health authorities advise the jabs for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, given the significant potential of relapse, the treatment is often ongoing.
This view is echoed by drug manufacturers, who state that the findings "highlight the chronic nature of excess weight," akin to managing diseases like diabetes.
Patient Testimonies
Individuals who have stopped the jabs report a intense resurgence of cravings.
"I experienced a switch that goes on and you become extremely hungry," said a patient.
This difficulty is compounded if users have not established lasting lifestyle or habit modifications during therapy.
Significant Interest
Recent estimates indicate that a significant number of people in the UK have used these injections in the last 12 months, with interest remaining high.
- Use is greater among females compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, researchers emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a standalone fix and long-term success relies on ongoing behavioural changes.